Literature DB >> 16615993

Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides.

Suzana K Straus1, Robert E W Hancock.   

Abstract

With the steady rise in the number of antibiotic-resistant Gram-positive pathogens, it has become increasingly important to find new antibacterial agents which are highly active and have novel and diversified mechanisms of action. Two classes will be discussed here: the cationic antimicrobial peptides, which are amphiphilic in nature, targeting membranes and increasing their permeability; and lipopeptides, which consist of linear or cyclic peptides with an N-terminus that is acylated with a fatty acid side chain. One member of the cyclic lipopeptide family, the anionic molecule daptomycin, has been extensively studied and is the major focus of this review. Models will be presented on its mode of action and comparisons will be made to the known modes of action of cationic antimicrobial peptides and other lipopeptides.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16615993     DOI: 10.1016/j.bbamem.2006.02.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  142 in total

1.  Daptomycin-mediated reorganization of membrane architecture causes mislocalization of essential cell division proteins.

Authors:  Joe Pogliano; Nicolas Pogliano; Jared A Silverman
Journal:  J Bacteriol       Date:  2012-06-01       Impact factor: 3.490

2.  Thermodynamics of Micelle Formation and Membrane Fusion Modulate Antimicrobial Lipopeptide Activity.

Authors:  Dejun Lin; Alan Grossfield
Journal:  Biophys J       Date:  2015-08-18       Impact factor: 4.033

3.  Daptomycin Resistance and Tolerance Due to Loss of Function in Staphylococcus aureus dsp1 and asp23.

Authors:  Elaine M Barros; Melissa J Martin; Elizabeth M Selleck; François Lebreton; Jorge Luiz M Sampaio; Michael S Gilmore
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

4.  Impact of Bacterial Membrane Fatty Acid Composition on the Failure of Daptomycin To Kill Staphylococcus aureus.

Authors:  Rym Boudjemaa; Clément Cabriel; Florence Dubois-Brissonnet; Nicolas Bourg; Guillaume Dupuis; Alexandra Gruss; Sandrine Lévêque-Fort; Romain Briandet; Marie-Pierre Fontaine-Aupart; Karine Steenkeste
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

5.  Characterization of the structure and membrane interaction of the antimicrobial peptides aurein 2.2 and 2.3 from Australian southern bell frogs.

Authors:  Yeang-Ling Pan; John T-J Cheng; John Hale; Jinhe Pan; Robert E W Hancock; Suzana K Straus
Journal:  Biophys J       Date:  2007-01-26       Impact factor: 4.033

6.  A novel synthesis of trans-unsaturated fatty acids by the Gram-positive commensal bacterium Enterococcus faecalis FA2-2.

Authors:  Tatiana Kondakova; Sneha Kumar; John E Cronan
Journal:  Chem Phys Lipids       Date:  2019-05-02       Impact factor: 3.329

Review 7.  A current perspective on daptomycin for the clinical microbiologist.

Authors:  Romney M Humphries; Simon Pollett; George Sakoulas
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

8.  Genetically engineered lipopeptide antibiotics related to A54145 and daptomycin with improved properties.

Authors:  Kien T Nguyen; Xiaowei He; Dylan C Alexander; Chen Li; Jian-Qiao Gu; Carmela Mascio; Andrew Van Praagh; Larry Mortin; Min Chu; Jared A Silverman; Paul Brian; Richard H Baltz
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

9.  Comparative mechanistic studies of brilacidin, daptomycin, and the antimicrobial peptide LL16.

Authors:  Bruk Mensa; Gabriella L Howell; Richard Scott; William F DeGrado
Journal:  Antimicrob Agents Chemother       Date:  2014-06-16       Impact factor: 5.191

10.  The isotridecanyl side chain of plusbacin-A3 is essential for the transglycosylase inhibition of peptidoglycan biosynthesis.

Authors:  Sung Joon Kim; Manmilan Singh; Aaron Wohlrab; Tsyr-Yan Yu; Gary J Patti; Robert D O'Connor; Michael VanNieuwenhze; Jacob Schaefer
Journal:  Biochemistry       Date:  2013-03-05       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.